Cue Biopharma Inc. (CUE)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

2,677,666 $31,195 -1% 0.88%
2.
Corriente Advisors

Mark Hart Iii

1,486,986 $17,323 -42% 9.34%
3.
Slate Path Capital

David Greenspan

1,483,619 $17,284 0.96%
4. 704,220 $8,204 +109% 0.28%
5.
Woodline PartnersKarl

Michael Rockefeller And Kroeker

667,224 $7,773 +229% 0.14%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$14.72 3,400 Officer, Director 55,377 2021-09-24 Filing
$15.07 2,720 Officer 4,720 2021-01-20 Filing
$12.64 6,548 Director 165,000 2020-11-24 Filing
$15.30 5,000 Director 677,500 2020-09-30 Filing
$15.00 5,000 Director 672,500 2020-09-29 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$14.21 1,251 Officer 10,472 2021-10-01 Filing
$15.23 20,000 Officer 74,838 2021-09-23 Filing
$15.09 439 Officer 2,000 2021-03-16 Filing
$15.10 13,000 Officer 2,000 2021-03-15 Filing
$15.06 4,274 Officer 2,000 2021-02-17 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 305,732 $4,103 0.74%
2. 4,950 $72 0%
3. 100 $1 0%
4. 0 $0 0%
News See All